跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
KALETRA TABLETS lopinavir 200mg and ritonavir 50mg tablets bottle
Approved
STANDARD
KALETRA TABLETS lopinavir 200mg and ritonavir 50mg tablets bottle
AbbVie Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
cc22249f81aab371
Company
AbbVie Pty Ltd
Type
Standard
Approval Details
Approval Id
cc22249f81aab371
Product Name
KALETRA TABLETS lopinavir 200mg and ritonavir 50mg tablets bottle
Artg Id
121055
Artg Name
KALETRA lopinavir 200mg and ritonavir 50mg tablets bottle
Sponsor
AbbVie Pty Ltd
Company Detail Path
/organization/abbvie-pty-ltd
Artg Date
2006-05-24
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/8fc1a75d39061d97a2f8ef5b4a52e6a6.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/c19c4e3d3fb7180ee08c6b08c910de7f.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
cc22249f81aab371
Type
Standard
Back to TGA Approvals
KALETRA TABLETS lopinavir 200mg and ritonavir 50mg tablets bottle - TGA Drug Approval Details
